AstraZeneca Trial on Hold Pending U.S. Scrutiny, Reuters Reports
A technician wearing a face mask analyses a blood sample in a serology lab at the Delhi Plasma Bank, for Covid-19 patients who will receive the trial antibody treatment, at the Institute of Liver and Biliary Sciences (ILBS) hospital in New Delhi, India. (Photographer: T. Narayan/Bloomberg)

AstraZeneca Trial on Hold Pending U.S. Scrutiny, Reuters Reports

(Bloomberg) -- AstraZeneca Plc’s Covid-19 vaccine trial remains on hold in the U.S. as regulators examine a serious side effect suffered by a U.K. patient, Reuters reported on Monday.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.